Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
Date:5/2/2013

V Prescribing Information, available at www.OFIRMEV.com or www.cadencepharm.com.

Non-GAAP Financial Measures This press release provides financial measures for net revenue, cost of sales, gross margin, net loss and basic and diluted loss per share that exclude specifically identified non-routine items, and are therefore not calculated in accordance with accounting principles generally accepted in the United States ("GAAP"). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance that enhances management's and investors' ability to evaluate and compare Cadence's operating results.

These non-GAAP financial measures are not intended to be used in isolation and should not be considered a substitute for any other performance measure determined in accordance with GAAP. Investors and potential investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool, including that other companies may calculate similar non-GAAP financial measures differently than Cadence, limiting their usefulness as a comparative tool. Cadence compensates for these limitations by providing specific information regarding the GAAP amount excluded from the non-GAAP financial measures. Cadence further compensates for the limitations of its use of non-GAAP financial measures by presenting comparable GAAP measures more prominently. Investors and potential investors are encouraged to review the calculation of non-GAAP financial measures contained within this press release with Cadence's GAAP net income and basic and diluted loss per share.

About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
4. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
5. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
6. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
7. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
8. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
9. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
10. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
11. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... July 27, 2015  Amgen (NASDAQ: AMGN ) ... financial results on Thursday, July 30, 2015, after the ... be followed by a conference call with the investment ... from Amgen will be Robert A. Bradway , ... Amgen,s senior management team. Live audio of ...
(Date:7/27/2015)... and FRANKLIN, Tenn. , July ... premier provider of health care services and one ... U.S., today announced that its parent company and ... definitive agreement with Medical Properties Trust, Inc. ("MPT") ... Capella for $900 million in cash.  The transaction is expected ...
(Date:7/27/2015)... , July 27, 2015 /PRNewswire/ - Quest PharmaTech ... company developing and commercializing products for the treatment of ... Quest announces that it has closed a $1,000,000 unit ... placement of 16,666,667 units of the Company at a ... of one common share and one common share purchase ...
(Date:7/27/2015)... ... July 27, 2015 , ... This ... industry.The report provides a basic overview of the industry including definitions, classifications, applications ... markets including development trends, competitive landscape analysis, and key regions development status. Development ...
Breaking Biology Technology:Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Quest PharmaTech Closes $1,000,000 Private Placement 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... Reportlinker.com announces that a new market research report ... Gene Therapy - technologies, markets and companies ... Summary Gene therapy can be ... material to specific target cells of a patient ...
... Nov. 30, 2011  Rhythm announced today that Lex Van ... Scientific Officer. Dr. Van der Ploeg brings to Rhythm ... obesity, metabolic diseases, and other therapeutic areas. ... of the metabolic pathways we are targeting with our ...
... 2011 Reportlinker.com announces that a new ... catalogue: Animal Biotechnology - ... http://www.reportlinker.com/p0203534/Animal-Biotechnology---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology Summary ... evaluates animal biotechnology and its application in ...
Cached Biology Technology:Gene Therapy - Technologies, Markets and Companies 2Gene Therapy - Technologies, Markets and Companies 3Gene Therapy - Technologies, Markets and Companies 4Gene Therapy - Technologies, Markets and Companies 5Gene Therapy - Technologies, Markets and Companies 6Gene Therapy - Technologies, Markets and Companies 7Gene Therapy - Technologies, Markets and Companies 8Gene Therapy - Technologies, Markets and Companies 9Gene Therapy - Technologies, Markets and Companies 10Gene Therapy - Technologies, Markets and Companies 11Gene Therapy - Technologies, Markets and Companies 12Gene Therapy - Technologies, Markets and Companies 13Gene Therapy - Technologies, Markets and Companies 14Gene Therapy - Technologies, Markets and Companies 15Gene Therapy - Technologies, Markets and Companies 16Gene Therapy - Technologies, Markets and Companies 17Gene Therapy - Technologies, Markets and Companies 18Gene Therapy - Technologies, Markets and Companies 19Gene Therapy - Technologies, Markets and Companies 20Gene Therapy - Technologies, Markets and Companies 21Rhythm Names Lex Van der Ploeg Chief Scientific Officer 2Animal Biotechnology - Technologies, Markets and Companies 2Animal Biotechnology - Technologies, Markets and Companies 3Animal Biotechnology - Technologies, Markets and Companies 4Animal Biotechnology - Technologies, Markets and Companies 5Animal Biotechnology - Technologies, Markets and Companies 6Animal Biotechnology - Technologies, Markets and Companies 7Animal Biotechnology - Technologies, Markets and Companies 8Animal Biotechnology - Technologies, Markets and Companies 9Animal Biotechnology - Technologies, Markets and Companies 10Animal Biotechnology - Technologies, Markets and Companies 11Animal Biotechnology - Technologies, Markets and Companies 12Animal Biotechnology - Technologies, Markets and Companies 13Animal Biotechnology - Technologies, Markets and Companies 14
(Date:7/23/2015)... DUBLIN , July 23, 2015 ... the addition of the "Global Outlook of ... their offering. The global biometrics ... both public and commercial applications owing to the ... will witness a transformation that enhances the growth ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market Intelligence,s ... The Convergence of Commerce and Privacy" forecasts that ... biometric apps will be downloaded to smart mobile ... mobile biometrics market is projected to generate more ... during the seven-year forecast period.    ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... good, but sometimes its better to be lucky. Ecologist ... St. Louis, had just completed a census of snakes at ... flood of 1993 deluged the area, putting the preserve at ... with a rare opportunity: His collected data and the flood ...
... have developed tools to help solve two of the main ... to quickly test stem cell response to different drugs or ... viable stem cells to study from only a few available ... of stems cells on devices the size of a standard ...
... several repeat operations as they grow, since the since ... for bigger ones. Researchers at Childrens Hospital Boston have ... the lab from a patients own cells. In ... describe making pulmonary valves through tissue engineering. These valves, ...
Cached Biology News:Ecologist finds dire devastation of snake species following floods of '93, '95 2Ecologist finds dire devastation of snake species following floods of '93, '95 3Ecologist finds dire devastation of snake species following floods of '93, '95 4Putting stem cell research on the fast track 2Putting stem cell research on the fast track 3Putting stem cell research on the fast track 4A step toward tissue-engineered heart structures for children 2
... system uses three Adept CE 4100 high pressure ... in one microlitre increaments. The Adept CE ... System control and data processing is provided by ... 4900., Column heater/chillers can be supplied. ...
... The excellent isocratic refractive index chromatography system, ... CE 4700. Data processing is provided ... delivery is by the high pressure CE 4100 ... can be supplied. The system can ...
Narrow-mouth has heavy-duty rim. Approximate graduations are in durable white enamel. Extra large marking space. capacity 125 mL Special grade: student grade...
...
Biology Products: